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In continuing our 10th anniversary celebrations, we asked women scientists in the metabolism field
to share their stories and words of wisdom for the new generation and are happy to present the first
12 Voices of our ‘‘Women in Metabolism’’ series.Miracles of Modern MedicineM. Celeste Simon, PhD Bei B. Zhang, PhDI went to medical school to understand
how the human bodyworks—especially
to learn about metabolism and hor-
mones. I wanted to help people learn
how to livewith chronic diseases. I never
planned to pursue research, but I
became acutely aware of the gaps in
knowledge and in therapeutic ap-
proaches for metabolic diseases. Re-
searchofferedopportunities for transfor-
mative discovery. I was inspired by the
discovery of insulin, one of the ‘‘miracles
of modern medicine,’’ and how it turned
a deadly childhood disease (type 1 dia-
betes) into a challenging but livable
lifestyle. The metabolism field has
expanded tremendously and is now
critical to fields such as cancer, stem
cell biology, neuroscience, and regene-
rative medicine. New hormones are
unveiling novel cellular pathways and
intertissue communication networks.
Amidst the excitement, two challenges
emerge. Understanding metabolism in-
vites multi-disciplinary collaborations
among biologists, chemists, engineers,
statisticians, etc. To sustain this pro-
ductive synergy, journals, funding agen-
cies, and universities need to continue
to find ways to recognize each collabo-
rator’s contributions in spite of author-
ship position. And as the ‘‘omics’’
era enables acquisition of daunting
amounts of data, we need to remind
young investigators that formulating
important questions and optimizing
experimental design are still paramount
to harness these tools for medical
advances. With that, we are poised for
the next ‘‘miracle of modern medicine.’’
Beth Israel Deaconess & Harvard Medical Schoolbolism 21, May 5, 2015 ª2015The Next Best QuestionI believe that real scientific success
comes from having the courage to ask
‘‘the next best question(s),’’ even when
entering unfamiliar territory. This applies
to our attempts to define metabolic
effects of tumor hypoxia on cancer
progression. O2 availability influences
many aspects of tumor growth; howev-
er, the impact of fluctuating O2 and
nutrient levels on metabolic reprogram-
ming inmalignancies (nowaburgeoning
field) was largely unstudied in 2002,
apart from the regulation of glycolytic
enzymes by HIFs. Inspired by the
ground-breaking work on oncogene/
tumor suppressor and metabolic cross-
talk by Craig Thompson and Chi Dang
in the late 1990s, our laboratory began
studying how HIFs ‘‘rewire’’ cancer cell
metabolism, an entirely new topic for
me. Craig and I submitted a program
project grant to the NCI on ‘‘Cancer
Cell Adaptations to Metabolic Stress’’
with other Penn investigators in 2003.
This proposal was initially met with sig-
nificant skepticism by its referees but
is now in its 11th year of continuous
funding. We have subsequently pub-
lished multiple papers in this area, and
I continue to learn more about cellular
bioenergetics, metabolic pathway flux
analyses, redox chemical reactions,
and biosynthetic homeostasis. How
metabolic pathways are influenced by
hypoxic/ischemic tumor microenviron-
ments was one of the ‘‘next big ques-
tions’’whenour laboratorybeganstudy-
ing them. Pushing ourselves beyond
our perceived boundaries is also one of
a scientific career’s true rewards.
University of Pennsylvania AbramsonCancer CenterElsevier Inc.Play to WinThe word ‘‘metabolism’’ literally means
‘‘removing the old’’ and ‘‘replenishing
with the new’’ in Chinese. This is
a constant process with the goal of
achieving an overall balance—or
homeostasis—that enables an organ-
ism to grow, thrive, and sustain. This
concept is not dissimilar to how we
grow, adapt, and learn in order to
establish a career in science with its
many challenges. The key, in my view,
is to always have a mindset of ‘‘play
to win,’’ where the ‘‘win’’ is advance-
ment of science for the greater good
of society. In our field, winning entails
the discovery of new molecular path-
ways and frontiers in human biology
that ultimately lead to novel therapies
to address unmet medical needs of
patients around the world. Moreover,
scientists thrive in a work environment
that embraces new and diverse ideas
and is supportive of collaborations
across disciplines and organizations.
Importantly, our ability to solve hard
problems also necessitates support
and mentorship and an unwavering
commitment in the form of patience
(and funding). The play to win approach
requires us to develop hypotheses,
test them rigorously, and then
follow the science relentlessly in our
quest for meaningful advances. Last,
as noted in a quote from Harvard
Business School alumnus Karen
Mills: ‘‘The best choices are those
where you can succeed and help
others to do so as well.’’ Together, we
play to win.
Eli Lilly and Company
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VoicesIt’s Time to Dream Big!Juleen R. Zierath
Karolinska Institutet and University of Copenhagen
Deborah M. Muoio, PhD
Duke Molecular Physiology Institute
Kathryn J. Moore, PhD
Professor, NewYork University School of MedicineWhen I grew up in the 1960’s, my
mother was required to have my father
cosign her bank and credit accounts! It
was not until 1974 when the Equal
Credit Opportunity Act passed that it
became illegal to refuse a credit card
to a woman based on her gender!
Against this background, I never imag-
ined I would lead international research
teams simultaneously in two countries
and have an impact on metabolic
research by addressing questions
related to exercise physiology and
type 2 diabetes.
Presently, I chair the Nobel Prize Com-
mittee for Physiology or Medicine at
Karolinska Institutet. Since 1901, only
11 of the 207 Laureates are women. I
am often asked ‘‘when will more
women be awarded?’’ I often reply
that we must follow Alfred Nobel’s will
and award the person who has made
the most important discovery within
physiology or medicine, irrespective
of nationality, religion, or gender. But
over the last decade, 5 women have
been recognized, marking a shift from
the last century.
More women lead cutting-edge dis-
covery research teams than ever
before as the gap between desire and
opportunity narrows. Yet, there is still
room to reach gender equality by
breaking down cultural barriers and
increasing the representation of
women in universities and decision-
making bodies. Like the great scien-
tists before us, a few special qualities
may help along your road to success:
dare to take yourself seriously, don’t
fear criticism, take a few risks, maintain
your work-life balance, and follow your
dreams.Girl Power Fuels MetabolismCell MetaOne of my most memorable experi-
ences as a graduate student was
attending a Keystone Diabetes Sympo-
sium in Park City, UT. The discovery of
leptin 2 years earlier set metabolic
research on a new trajectory, and the
energy in the room was palpable.
Listening to the talks, I knew with cer-
tainty I had landed on the right career
path. The field was clearly dominated
by men, but I drew inspiration from
female role models who were paving
the way for women in metabolism,
e.g., Rosalind Coleman, Barbara
Kahn, Barbara Corkey, and Barbara
Cannon. 14 years later, I was honored
by an invitation to organize a Keystone
meeting. My journey has been chal-
lenging and rewarding. I matriculated
at UNC in 1994 and gave birth to my
son Michael a year later. I’m often
asked, ‘‘How did you balance career
goals and motherhood?’’ My answer:
discipline, hard work, focus, careful
planning, efficiency, teamwork, and a
supportive partner—all essential. It’s
important that women don’t fall back
on work/family balance as a reason to
underperform. Progress toward gender
equity requires that women in science
set high goals and maintain high stan-
dards. Supportive mentors are also a
must. I’ve had many, both men and
women, who aggressively campaigned
on my behalf. Many women struggle
with self-promotion. In general, men
are more comfortable tooting their
own horns. Women tend to ask after
they deliver; men ask first and promise
to deliver. Maybe we should take some
lessons from the guys!bolismForging Your Own PathwayHow do you succeed as a woman in
science? It is a question I get asked a
lot. As a graduate student and post-
doc, I heard much advice on this sub-
ject: assume a serious demeanor,
never wear girly clothing, and avoid
talking about your kids for fear of being
placed on the mommy track instead of
the tenure track. While I fretted about
how to gain acceptance and advance
in a male-dominated field, my hus-
band, a scientist whose own work
uniform consisted of free T-shirts from
assorted lab vendors, would watch
me in consternation and say, ‘‘Just do
great science—that is all that matters.’’
As my career progressed, I learned
that for women in academia, reality
lies somewhere between these two
sartorial extremes. A career in science
is challenging regardless of gender,
and to excel you need to develop a
diverse array of skills. Critical thinking,
imagination, and persistence are the
obvious ones, but you need likewise
to be a talented writer, public speaker,
mentor, and manager of people and
resources. As a partner and mother,
you need to accomplish all of this
with less sleep and more demands on
your time. It can be exhausting, if
not impossible, to live up to all those
expectations simultaneously. So how
does one succeed? Along the way,
I’ve learned that finding the right
mentors (both male and female) to
give you perspective, building a strong
team that supports your vision, being
open to the unexpected, and believing
in yourself make up half the battle—
the rest is luck.21, May 5, 2015 ª2015 Elsevier Inc. 655
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VoicesA Life with Brown FatBarbara Cannon
Professor of Physiology, Currently President of
the Royal Swedish Academy of Sciences
For 27 years, Director of the Wenner-Gren
Institute, Stockholm University
Marcia Haigis
Associate Professor of Cell Biology, Harvard Med-
ical School
Kristina Schoonjans
Ecole Polytechnique Fe´de´rale de Lausanne,
SwitzerlandI left London after my Bachelor’s
degree because (a) I wanted to test
how it was to live abroad and (b) I
wanted to study mitochondria. That
my scientific life became brown adi-
pose tissue was an unforeseen con-
sequence of these premises! Thus,
one often makes small decisions and
then finds that the life-long, major
decisions have just happened. At that
time, there were few women in the
field, so it was relatively easy to be
remembered. In retrospect, I would
say that if one wants to juggle every-
thing in life, the most important issue
is to choose a partner who is support-
ive and understanding—and to work
in a country with good child care! Of
course, there are many more people
around now, a change that is encour-
aging, but there is also greater stress,
which unfortunately appears to be
leading to less-perceptive articles, not
least even among those appearing
in high-impact journals. And society
exerts pressure to deliver results
in translational research—something
within a politician’s timeframe—at the
cost of fundamental, explorative work,
the work that the next generation’s
progress will depend on. However,
it has been fulfilling to participate in
brown adipose tissue research as it
has progressed from being esoteric to
being (more than) mainstream. Thus,
science remains a challenge; that’s
why scientists never retire, we just
fade away.656 Cell Metabolism 21, May 5, 2015 ª2015Outside the ‘‘Norm’’I am in awe of the elegance of nature—
how molecular interactions can be de-
ployed to carry out distinct functions
in different contexts. My career has
been shaped by pursuing questions
that lie outside the ‘‘norm’’ of the field.
I am driven by the urge to identify
fundamental mechanisms that control
mitochondrial biology in non-traditional
systems, such as cancer. It can be
tough, but I advise young scientists to
be bold about seeking out dedicated
(male and female) mentors who will
give frank advice. It is also important
to develop a thick skin and confidence
and to stick to the questions and
approach you feel passionate about.
I try to be generous with colleagues
and collaborators. For me, one of the
most exciting parts of science is the
synergy from exchanging ideas, tools,
and discoveries. Looking back at
stages of my training, I have chosen
career transitions that provided me
with the most flexible opportunities
for the future. Finally, with three small
children and a husband who is also a
scientist, my family could be consid-
ered outside the ‘‘norm.’’ I am prag-
matic about not needing to balance all
aspects of my life at every moment,
but instead work to recognize seasons
for personal or professional growth.Elsevier Inc.Science as a Team EffortThe identification that metabolites are
not mere intermediates of metabolic
pathways, but serve also as signal
transducers and transcriptional and
epigenetic regulators, has been a
major breakthrough with wide-ranging
implications. My passion to study me-
tabolites, and bile acids in particular,
was triggered by the concept that
many nuclear receptors act as sensors
of metabolites. With the discovery that
bile acids also activate membrane
receptors, they have become center
stage in the signaling field, and further
research will undoubtedly unveil other
unanticipated functions of these pleio-
tropic molecules. I share this passion
for metabolism with my husband, with
whom I have worked together now for
more than 20 years. We always felt
that team spirit is the key to scientific
success. It is the right combination
of people that makes the difference—
like selecting the best ingredients
for a meal. While our synergies have
definitely worked to our mutual
benefit—scientifically, economically,
and for management—it is no secret
that our longstanding collaboration
has also occasionally led to prejudices
and institutional biases. Time has pro-
ven that scientific couples are vulner-
able as well, especially if this modus
operandi is not fully embraced by the
scientific environment. With the com-
mon view that preventive medicine
and natural compounds is the future
path to take, we will continue our
research in that direction—with our
complementary strengths and values.
Cell Metabolism
VoicesGenomes and FatSusanne Mandrup
University of Southern Denmark, Odense,
Denmark
Karine Clement, MD, PhD
Institute of Cardio-metabolism and Nutrition,
ICAN, Paris, France
Nancy C. Andrews, MD, PhD
Dean, Duke University School of MedicineMy fascination with genomes and their
regulation has been a driving force
throughout my career. As a PhD stu-
dent, I was introduced to the world of
lipid-binding proteins, and since then I
have had a dual passion for genomes
and lipid metabolism. This led me into
the field of nuclear receptors and
triggered my interest in adipocyte dif-
ferentiation. I was lucky to spend a
short postdoc with M. Daniel Lane at
Johns Hopkins University and was
hugely inspired by him and his lab.
For family reasons, I couldn’t stay
longer than 14 months, but it was by
far the most important year in my
career. Combining family and career
clearly requires compromises at both
ends and a good spouse. I had kids
during my PhD, and although my su-
pervisor told me he did not think it
was a great idea, in retrospect, the
timing was probably the best possible
for me. After about 2.5 years, my kids
had become less dependent, my
husband had accepted to take leave,
and we moved to Baltimore on what
turned out to be a fantastic adventure
for all of us. After a few years back in
Denmark, I established my own lab.
Despite all the challenges, it has been
a fantastic and rewarding process.
It is a great privilege to work in an
environment with so many opportu-
nities and passionate people. Lately,
what has excited me the most is the
ability to study gene regulation at
a genome-wide level. This has truly
revolutionized our understanding of
genomes and transcription and made
it more fun than ever to work in this
field.Women MDs and ResearchThe low representation of women
combining clinical practice with
research at faculty level is well docu-
mented. The old recipe of expecting
doctors to dedicate a few hours to
research, while still seeing patients,
has for the biggest part failed in pro-
moting a simultaneous career path.
The competition for research funds
and the high dedication expected
from physicians make it exceedingly
difficult to succeed in both. Although
this is a chosen path for some MD-
PhD professionals, it is becoming
increasingly difficult to attract women
in particular. Indeed, both clinical
practice and science require special-
ized skills, but young MDs rarely see
the need for this type of career
complexity in a world of specialization.
Perhaps we are not convincing them
that the combined training can actually
help them make sophisticated deci-
sions that are based on complex
inputs of data. We are also failing to
show them that physician/scientists
are the ideal individuals for bridging
the subspecialties of science and
medicine in a meaningful, functional,
and patient-oriented manner. Women
are particularly inclined to tackle
complex professional and personal
issues and build inclusive commu-
nities. It would therefore behoove
policymakers, deans of schools, and
government officials to facilitate the
recruitment of women in dual clinical/
research career paths.Cell Metabolism4 Tips for Young ScientistsRecently, I dug up old treasures to
prepare a talk: a 1978 autoradiogram
that used more 32P than any lab would
own today, a photo of a protein band
that gave peptide sequence to clone
the protein that defined my postdoc,
a histology slide that explained a
patient’s disease, and a high-profile
paper reporting a mistake—not entirely
my mistake, but by correcting it I laid
the foundation formy 20 years studying
iron homeostasis.
I recognized four themes that had
helped me succeed. (1) Interesting
science comes from many different
directions. It can be a surprise, like
the key control that changed the scope
of my PhD dissertation; a real, honest
mistake, like the one that got me into
iron; or something unexpected. Good
data are always right, but our inter-
pretations often aren’t. (2) Old papers
still matter. Elegant papers from the
1940s and 1950s laid out much of
what we know about iron homeostasis.
The ideas were there; we just charac-
terized the molecules involved. (3)
New technologies level the playing
field. You don’t have to invent them,
but quickly adopt those that can
enhance your science. We wanted
to use positional cloning to find iron
transporter genes in the 1990s, but
I was dissuaded because I didn’t
know genetics. We did it anyway.
Gene mapping changed so quickly
that it didn’t matter. (4) Choose impor-
tant questions, not boring questions.
Be brave and stick with your questions
even when they’re hard. You’ll even-
tually find the answers, and these
answers will really matter.21, May 5, 2015 ª2015 Elsevier Inc. 657
